Outcomes With Fractional Flow Reserve in Chronic Coronary Syndrome
Prognostic Impact of Fractional Flow Reserve in Chronic Coronary Syndrome: Quasi-Experimental Findings Using a Regression Discontinuity Design
1 other identifier
observational
5,000
0 countries
N/A
Brief Summary
The use of fractional flow reserve (FFR) to assess the functional relevance of coronary stenoses has been demonstrated to reduce the risk urgent revascularization in chronic coronary syndrome patients.\[1\] The goal of this study is to assess whether the utility of using FFR during percutaneous coronary intervention (PCI) in chronic coronary syndrome patients is confirmed in a real-life scenario. This study will implement a regression discontinuity design (RDD). RDD is a quasi-experimental study design able to provide robust findings on causality using observational data.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
October 17, 2022
CompletedFirst Posted
Study publicly available on registry
October 24, 2022
CompletedOctober 24, 2022
October 1, 2022
5 years
October 17, 2022
October 20, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk difference (%) for the composite of all-cause death and FFR-oriented target vessel revascularization by PCI
Up to one year following index FFR measurement
Secondary Outcomes (3)
Risk difference (%) for the composite of all-cause death, FFR-oriented target vessel revascularization by PCI and hospitalization for acute myocardial infarction
Up to one year following index FFR measurement
Risk difference (%) for the composite of all-cause death and new hospitalization for acute myocardial infarction
Up to one year following index FFR measurement
Risk differences (%) for the individual components of the composite outcome measures
Up to one year following index FFR measurement
Study Arms (2)
FFR below 0.80
Patients with significant coronary hyperemic gradient
FFR above 0.80
Patients without significant coronary hyperemic gradient
Interventions
Coronary revascularization performed by PCI in a vessel investigated with FFR or indication for surgery
Eligibility Criteria
Patients with chronic coronary syndrome undergoing coronary angiography and FFR measurement in Sweden.
You may qualify if:
- Chronic coronary syndrome undergoing coronary angiography and FFR measurement
- Swedish personal identification number
You may not qualify if:
- previous coronary artery bypass grafting
- left main disease or undergoing FFR/PCI of left main
- IVUS/OCT use
- diffuse disease (≥ 2 segments treated in a same vessel investigated with FFR, ≥ 2 segments investigated with FFR in a same vessel)
- PCI in a distal segment with respect to FFR measurements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N, Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T, Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N, Johnson JB, Juni P, Fearon WF; FAME 2 Trial Investigators. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012 Sep 13;367(11):991-1001. doi: 10.1056/NEJMoa1205361. Epub 2012 Aug 27.
PMID: 22924638BACKGROUNDJernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, Lagerqvist B, Lindahl B, Stenestrand U, Wallentin L. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010 Oct;96(20):1617-21. doi: 10.1136/hrt.2010.198804. Epub 2010 Aug 27.
PMID: 20801780BACKGROUNDCalonico S, Cattaneo MD, Farrell MH. Optimal bandwidth choice for robust bias corrected inference in regression discontinuity designs. Econom J. 2020;23(2):192-210.
BACKGROUNDCalonico S, Cattaneo MD, Titiunik R. Robust nonparametric confidence intervals for regression-discontinuity designs. Econometrica. 2014;82(6):2295-2326.
BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2022
First Posted
October 24, 2022
Study Start
June 1, 2015
Primary Completion
June 1, 2020
Study Completion
June 1, 2020
Last Updated
October 24, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will not share